Hepatocellular carcinoma development in cirrhosis.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Best practice & research. Clinical gastroenterology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.BPG.2006.07.002PMID 17223503
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular pathogenesis of hepatocellular carcinoma

  2007cited by this paper
• Prevention of Second Primary Tumors by an Acyclic Retinoid in Patients with Hepatocellular Carcinoma

  2005cited by this paper
• Effect of Long-Term Postoperative Interferon Therapy on Intrahepatic Recurrence and Survival Rate after Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma

  2005cited by this paper
• Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients.

  2005cited by this paper
• Development of Hepatocellular Carcinoma after Interferon Therapy in Chronic Hepatitis C

  2005cited by this paper
• Clinicopathologic features of patients with primary malignant hepatic tumors seropositive for α‐fetoprotein‐L3 alone in comparison with other patients seropositive for α‐fetoprotein‐L3

  2005cited by this paper
• Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver.

  2004cited by this paper
• Lamivudine for patients with chronic hepatitis B and advanced liver disease.

  2004cited by this paper
• Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

  2004cited by this paper
• Hepatocellular carcinoma: recent trends in the United States.

  2004cited by this paper
• Acyclic retinoid in the chemoprevention of hepatocellular carcinoma (review).

  2004cited by this paper
• Interferon Therapy after Tumor Ablation Improves Prognosis in Patients with Hepatocellular Carcinoma Associated with Hepatitis C Virus

  2003cited by this paper
• Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection.

  2002cited by this paper
• Characteristics of liver cancer in Japan comparison with liver cancer in foreign countries

  2002cited by this paper
• Acyclic retinoid induces partial differentiation, down-regulates telomerase reverse transcriptase mRNA expression and telomerase activity, and induces apoptosis in human hepatoma-derived cell lines.

  2002cited by this paper
• Outcome of patients with hepatitis C virus-related hepatocellular carcinoma occurring after interferon therapy.

  2002cited by this paper
• Synergistic induction of apoptosis by acyclic retinoid and interferon‐β in human hepatocellular carcinoma cells

  2002cited by this paper
• Trend of liver cirrhosis as precancerous lesions

  2002cited by this paper
• Effects of Long-Term Postoperative Interferon- Therapy on Intrahepatic Recurrence after Resection of Hepatitis C VirusRelated Hepatocellular Carcinoma

  2001cited by this paper
• Comparison of clinicopathological features of patients with hepatocellular carcinoma seropositive for α‐fetoprotein alone and those seropositive for des‐γ‐carboxy prothrombin alone 1

  2001cited by this paper
• Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial.

  2001cited by this paper
• Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses.

  2000cited by this paper
• Hepatitis C virus

  1999cited by this paper
• Schiff's diseases of the liver

  1999cited by this paper
• Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients.

  1999cited by this paper
• The long‐term outcomes of patients with compensated hepatitis C virus–related cirrhosis and history of parenteral exposure in the united states

  1999cited by this paper
• Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma.

  1999cited by this paper
• Measurement of serum levels of des‐γ‐carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity

  1999cited by this paper
• Prevention of Second Primary Tumors by an Acyclic Retinoid, Polyprenoic Acid, in Patients with Hepatocellular Carcinoma

  1998cited by this paper
• The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

  1998cited by this paper
• Immune Pathogenesis of Hepatocellular Carcinoma

  1998cited by this paper
• Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C

  1998cited by this paper
• Hepatitis C virus and hepatocellular carcinoma.

  1998cited by this paper
• Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein.

  1997cited by this paper
• The long term efficacy of glycyrrhizin in chronic hepatitis C patients

  1997cited by this paper
• Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.

  1997cited by this paper
• Transcriptional Repression of p53 Promoter by Hepatitis C Virus Core Protein*

  1997cited by this paper
• Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype

  1996cited by this paper
• Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma.

  1996cited by this paper
• Suppression of apoptotic cell death by hepatitis C virus core protein.

  1996cited by this paper
• Hepatocellular carcinoma in Asia

  1996cited by this paper
• Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas.

  1995cited by this paper
• Characteristic difference of hepatocellular carcinoma between hepatitis B‐ and C‐ viral infection in Japan

  1995cited by this paper
• A preliminary trial of lamivudine for chronic hepatitis B infection.

  1995cited by this paper
• A comparison of the surgical results in patients with hepatitis B versus hepatitis C‐related hepatocellular carcinoma

  1995cited by this paper
• Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells

  1995cited by this paper
• Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

  1995cited by this paper
• Telomeres, cancer, and immortality.

  1995cited by this paper
• HCV-associated liver cancer without cirrhosis.

  1995cited by this paper
• Specific association of human telomerase activity with immortal cells and cancer.

  1994cited by this paper
• Positive and negative regulations of albumin gene expression by retinoids in human hepatoma cell lines

  1994cited by this paper
• Hepatology Elsewhere correspondence. Hepatocellular carcinoma and viral cirrhosis

  1994cited by this paper
• Hepatocellular carcinoma and viral cirrhosis.

  1994cited by this paper
• A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis

  1993cited by this paper
• Molecular Pathogenesis of Liver Disease During Persistent Hepatitis B Virus Infection

  1992cited by this paper
• Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus

  1990cited by this paper
• Hepatocellular carcinoma in woodchuck hepatitis virus‐infected woodchucks: Presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections

  1989cited by this paper
• Viral hepatitis and liver disease

  1984cited by this paper
• Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.

  1984cited by this paper
• Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan.

  1981cited by this paper
• HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS. A Prospective Study of 22 707 Men in Taiwan

  1981cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• Network-base approaches to identify therapeutic biomarkers in hepatocellular carcinoma and search for drug hunting utilizing molecular dynamics simulations

  2024cites this paper
• Letter: Filling the Gaps—Enhancing MASLD Prognosis With Imaging, Diverse Populations and Extended Follow‐Up

  2024cites this paper
• Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma

  2023cites this paper
• Mitochondrial Dysfunction and Induction of Apoptosis in Hepatocellular Carcinoma and Cholangiocarcinoma Cell Lines by Thymoquinone

  2022cites this paper
• Signaling Pathways Tuning Innate Lymphoid Cell Response to Hepatocellular Carcinoma

  2022cites this paper
• Scoring systems for the management of oncological hepato-pancreato-biliary patients

  2022cites this paper
• Silencing CDCA8 Suppresses Hepatocellular Carcinoma Growth and Stemness via Restoration of ATF3 Tumor Suppressor and Inactivation of AKT/β–Catenin Signaling

  2021cites this paper
• The effect of some phytochemical combinations on liver disorders induced by carbon tetrachloride in rats

  2021influential citation
• Anti-Hepatocellular Carcinoma Biomolecules: Molecular Targets Insights

  2021cites this paper
• External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population

  2021cites this paper
• Targeting CALM2 Inhibits Hepatocellular Carcinoma Growth and Metastasis by Suppressing E2F5-mediated Cell Cycle Progression

  2021cites this paper
• The gut microbiome-bile acid axis in hepatocarcinogenesis.

  2021cites this paper
• Interleukin 22 is related to development and poor prognosis of hepatocellular carcinoma.

  2020cites this paper
• New LncRNAs in Chronic Hepatitis C progression: from fibrosis to hepatocellular carcinoma

  2020cites this paper
• Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma

  2020cites this paper
• Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.

  2019cites this paper
• The role of tacstd-2 level in hepatitis C patients (controlled clinical research)

  2019cites this paper
• Innovative molecular targeted agents in hepatocellular carcinoma: new gladiators on the arena.

  2017cites this paper
• Practical Considerations of Real Life of Hepatocellular Carcinoma in a Tertiary Center of Brazil.

  2017cites this paper
• Preparation, characterization and evaluation of (186) Re-idarubicin: a novel agent for diagnosis and treatment of hepatocellular carcinoma.

  2016cites this paper
• Vaccination Age Changing from Infancy and Childhood to Adolescence andAdulthood: An In-Dispensable Approach in Immunization Programs

  2016cites this paper
• Trends and Patterns of Hepatocellular Carcinoma Treatment in Korea

  2016cites this paper
• A novel curcumin analogue is a potent chemotherapy candidate for human hepatocellular carcinoma.

  2016cites this paper
• Targeting ODC1 inhibits tumor growth through reduction of lipid metabolism in human hepatocellular carcinoma.

  2016cites this paper
• Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin

  2016cites this paper
• miRNA for diagnosis and clinical implications of human hepatocellular carcinoma

  2016cites this paper
• Multimodal approach of advanced gastric cancer: based therapeutic algorithm.

  2016cites this paper
• Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON

  2016cites this paper
• Molecular Targeted Therapy for Hepatocellular Carcinoma: Present Status and Future Directions.

  2015cites this paper
• [Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy].

  2015cites this paper
• MicroRNA301 is a potential diagnostic biomarker for hepatocellular cancer.

  2015cites this paper
• Brazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinoma.

  2015cites this paper
• Curcumin ameliorate DENA-induced HCC via modulating TGF-β, AKT, and caspase-3 expression in experimental rat model

  2015cites this paper
• Can we use Sorafenib for advanced Hepatocellular Carcinoma (HCC) Child Pugh B?

  2015cites this paper
• Signal transducer and activator of transcription 3‐mediated CD133 up‐regulation contributes to promotion of hepatocellular carcinoma

  2015cites this paper
• Sorting Out Pandora’s Box: Discerning the Dynamic Roles of Liver Microenvironment in Oncolytic Virus Therapy for Hepatocellular Carcinoma

  2014cites this paper
• Inflammatory response of endothelial cells to hepatitis C virus recombinant envelope glycoprotein 2 protein exposure

  2014cites this paper
• Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and PAI-1 mRNA transcription.

  2014cites this paper
• Preventive effect of hydrazinocurcumin on carcinogenesis of diethylnitrosamine-induced hepatocarcinoma in male SD rats.

  2014cites this paper
• Compound Astragalus and Salvia miltiorrhiza extracts suppress hepatocarcinogenesis by modulating transforming growth factor‐β/Smad signaling

  2014cites this paper
• Inflammatory response of endothelial cells to hepatitis C virus recombinant envelope glycoprotein 2 protein exposure.

  2014cites this paper
• OCCULT HEPATITIS B VIRUS INFECTION IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION AND HEPATOCELLULAR CARCINOMA

  2014cites this paper
• Preventive Effect of Hydrazinocurcumin on DEN-induced Hepatocarcinogenesis in Male SD Rats

  2014cites this paper
• University of Alberta Mitochondrial Dysfunction and Induction of Apoptosis in Hepatocellular Carcinoma and Cholangiocarcinoma Cell Lines by Thymoquinone by

  2014cites this paper
• [Oncologic imaging: indications for and limitations of modern cross-sectional imaging techniques].

  2013cites this paper
• Phosphatidylinositol 4 -Kinases de type III hépatiques : implication au cours de l'infection par le virus de l'hépatite C et lien avec le carcinome hépatocellulaire

  2013cites this paper
• GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis

  2013cites this paper
• Antifibrotic properties of transarterial oncolytic VSV therapy for hepatocellular carcinoma in rats with thioacetamide-induced liver fibrosis.

  2013cites this paper
• Lifrarígræðslur á Íslandi

  2013cites this paper
• Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?

  2012cites this paper
• Preventive effect of caffeine and curcumin on hepato-carcinogenesis in diethylnitrosamine-induced rats.

  2012cites this paper
• Hepatocellular Carcinoma: Focus on Different Aspects of Management

  2012cites this paper
• Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy: A Population-Based Cohort Study

  2012cites this paper
• Treatment of Chronic Viral Hepatitis B and Drug Resistant Variants

  2012cites this paper
• Interação da proteina e2 do vírus da hepatite c com o receptor de ldl e cd81 presentes em células endoteliais e ativação da resposta inflamatória

  2012cites this paper
• Isoflavones-Enriched Soy Protein Prevents CCL4-Induced Hepatotoxicity in Rats

  2012cites this paper
• Risk factors of hepatocellular carcinoma--current status and perspectives.

  2012cites this paper
• An Histopathological and Stereological Study Of Proliferative Hepatocellular Lesions In A Fish Model of Experimental Carcinogenesis And In a Sentinel Fish

  2011cites this paper
• Impact of Single Nucleotide Polymorphism of TGF-β1 Gene (SNP-Codon10) on Hepatocellular Carcinoma Risk in Egyptian Patients Following HCV Infection

  2011cites this paper
• Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population

  2011cites this paper
• Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma

  2011cites this paper
• Using loss of heterozygosity of microsatellites to distinguish high-grade dysplastic nodule from early minute hepatocellular carcinoma.

  2011cites this paper
• Hot water extracted Lycium barbarum and Rehmannia glutinosa inhibit liver inflammation and fibrosis in rats.

  2011cites this paper
• Association of hypomethylation of LINE-1 repetitive element in blood leukocyte DNA with an increased risk of hepatocellular carcinoma

  2011cites this paper
• Preventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on DEN-induced hepatocarcinogenesis in rats.

  2010cites this paper
• Hepatitis B virus-related hepatocarcinogenesis: molecular oncogenic potential of clear or occult infections.

  2010cites this paper
• [New possibilities of targeted therapy in the treatment of hepatocellular carcinoma with the help of molecular biology].

  2010cites this paper
• Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor‐β/Smad in HepG2 cell

  2010cites this paper
• Association of Genetic Polymorphisms in STAT1 Gene with Increased Risk of Hepatocellular Carcinoma

  2010cites this paper
• MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption.

  2009cites this paper
• Histone deacetylase inhibition and the regulation of cell growth with particular reference to liver pathobiology

  2009cites this paper
• Autoimmune hepatitis in Sweden

  2009cites this paper
• Hepatitis C virus targets over‐expression of arginase I in hepatocarcinogenesis

  2009cites this paper
• Title Natural history of hepatitis-related hepatocellular carcinoma

  2009cites this paper
• Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patients.

  2009cites this paper
• Association of MicroRNAExpression in Hepatocellular Carcinomas with Hepatitis Infection , Cirrhosis , and Patient Survival

  2008cites this paper
• Natural history of hepatitis-related hepatocellular carcinoma.

  2008cites this paper
• Using SELDI-TOF-MS technology for screening serum markers of hepatic carcinoma in rats * * This stud

  2008cites this paper
• Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway.

  2008cites this paper
• Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival

  2008cites this paper
• [Epidemiology, risk factors and molecular pathogenesis of primary liver cancer].

  2008cites this paper
• TGF-beta1 genotypes in cirrhosis: relationship with the occurrence of liver cancer.

  2008cites this paper
• Role of the Hepatitis B Virus in Hepatocellular Carcinoma

  2008cites this paper
• Dual Therapeutic Effects of Interferon-α Gene Therapy in a Rat Hepatocellular Carcinoma Model With Liver Cirrhosis.

  2008cites this paper
• Mechanisms of anti-proliferative effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on human liver cancer cells.

  2007cites this paper
• Identification of differential expression of genes in hepatocellular carcinoma by suppression subtractive hybridization combined cDNA microarray.

  2007cites this paper
• Clinical Interventions in Aging Dovepress

  year unknowncites this paper
• Dual Therapeutic Effects of Interferon-α Gene Therapy in a Rat Hepatocellular Carcinoma Model With Liver Cirrhosis

  year unknowncites this paper